13 results
·
23ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
AiMIFY (1.x)
FDA 510(k)
FDA Class 2
·Radiology
OMNI Knee
FDA UDI
Omni Life Science, Inc.·00841690101925·All Poly 3 Peg Patella 29 mm x 10 mm
APEX Knee System
FDA UDI
Omni Life Science, Inc.·00841690199311·Patella Trial 29mm x 10mm
T:SLIM X2 INSULIN PUMP WITH CONTROL-IQ TECHNOLOGY
FDA Adverse Event
Malfunction
·TANDEM DIABETES CARE·Product code QFG·July 7, 2021
STOPLOSS JONES TUBE
FDA 510(k)
FDA Unclassified
·Unknown
DIASORIN LIAISON CMV IGM/IGG
FDA 510(k)
FDA Class 2
·Microbiology
OT ULTRAMINI METER
FDA Adverse Event
Malfunction
·LIFESCAN EUROPE GMBH·Product code NBW·July 10, 2019
INTERLINK I.V. CONN LOOP/MALE LUER SLIP ADAPTER
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE CORPORATION·Product code FPA·November 24, 2008
TENDRIL STS
FDA Adverse Event
Injury
·ST JUDE MEDICAL CARDIAC RHYTHM MANAGEMENT DIVISION·Product code DTB·September 9, 2011
ENOSCOPIC GASTRO RELEASE SYSTEM (EGR138)
FDA Adverse Event
Injury
·INTEGRA LIFESCIENCES CORPORATION·Product code NBH·July 18, 2013
TRUE METRIX
FDA Adverse Event
Malfunction
·TRIVIDIA HEALTH INC·Product code NBW·October 20, 2023
MOLLI 2 System System includes: MM1000 (Pack of 10) - MOLLI Introducer (8cm, 14G) and MOLLI Marker UDI (GTIN): 00850024195028 MS-00009 (Pack of 10) - MOLLI Introducer (12cm, 14G) and MOLLI Marker UDI (GTIN): 00850024195134 MP2001 - MOLLI 2 Wand UDI (GTIN): 00850024195141 MP2015A - MOLLI OncoPen UDI (GTIN): 00850024195219 MT2001 - MOLLI 2 Tablet UDI (GTIN): 00850024195158 The MOLLI Marker is intended to be placed percutaneously in soft tissue to temporarily mark a surgical site intended for surgical removal. the MOLLI Marker is located and surgically removed with the target tissue.
FDA Enforcement
Class II
·Ongoing·Stryker Corporation·February 25, 2026
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models F102, F110, F111. Sterilized using ethylene oxide. Boston Scientific, 4100 Hamline Avenue North, St. Paul, MN 55112-5798 USA. Indicated for patients who are at risk for sudden cardiac death due to ventricular arrhythmias and may require pacing support.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 23, 2013